
Results
165
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
165 companies
Nang Kuang Pharmaceutical
Market Cap: NT$3.9b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$38.80
7D
0%
1Y
-11.6%
Mochida Pharmaceutical
Market Cap: JP¥109.5b
Manufactures and sells pharmaceuticals and healthcare products in Japan.
4534
JP¥3,090.00
7D
4.8%
1Y
-7.5%
Abbott Laboratories (Pakistan)
Market Cap: PK₨108.0b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,103.33
7D
-1.5%
1Y
23.0%
Auxly Cannabis Group
Market Cap: CA$209.0m
Operates as a consumer packaged goods company in the cannabis products market in Canada.
XLY
CA$0.15
7D
-3.1%
1Y
210.0%
Sichuan Goldstone Asia Pharmaceutical
Market Cap: CN¥4.6b
Sichuan Goldstone Asia Pharmaceutical Inc.
300434
CN¥11.51
7D
4.8%
1Y
25.0%
Traphaco
Market Cap: ₫2.7t
Produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam.
TRA
₫66,300.00
7D
-0.7%
1Y
-13.9%
HOB Biotech GroupLtd
Market Cap: CN¥11.6b
Operates as a in vitro diagnostic company in China and internationally.
688656
CN¥185.00
7D
12.6%
1Y
61.1%
Amrutanjan Health Care
Market Cap: ₹20.5b
Manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally.
590006
₹707.85
7D
-2.3%
1Y
0.1%
Shanghai Shenqi Pharmaceutical Investment Management
Market Cap: CN¥3.3b
Operates as a pharmaceutical manufacturing holding investment company in China.
600613
CN¥6.56
7D
1.4%
1Y
-15.6%
Zhejiang AngLiKang PharmaceuticalLTD
Market Cap: CN¥7.4b
A pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases.
002940
CN¥37.70
7D
-5.1%
1Y
161.8%
GuangYuYuan Chinese Herbal Medicine
Market Cap: CN¥9.8b
GuangYuYuan Chinese Herbal Medicine Co., Ltd.
600771
CN¥20.00
7D
4.5%
1Y
-5.1%
Shanghai Xiao Fang PharmaceuticalLtd
Market Cap: CN¥5.2b
Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China.
603207
CN¥32.16
7D
-0.6%
1Y
13.4%
Zhejiang Cheng Yi Pharmaceutical
Market Cap: CN¥3.7b
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
603811
CN¥11.65
7D
-2.2%
1Y
41.4%
Nanjing Hicin Pharmaceutical
Market Cap: CN¥6.7b
Engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates.
300584
CN¥55.58
7D
-9.4%
1Y
141.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$11.2b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$28.00
7D
0%
1Y
365.9%
Saniona
Market Cap: SEK 2.1b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 15.56
7D
-1.4%
1Y
421.3%
DHG Pharmaceutical
Market Cap: ₫13.5t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫103,100.00
7D
-2.4%
1Y
0.2%
PharmaEngine
Market Cap: NT$9.8b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$68.00
7D
-4.4%
1Y
-34.0%
Imexpharm
Market Cap: ₫7.5t
Manufactures, processes, trades in, imports, and exports pharmaceutical products in Vietnam and internationally.
IMP
₫48,650.00
7D
-2.9%
1Y
10.6%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.5b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
002437
CN¥3.36
7D
-1.2%
1Y
21.7%
Suzhou Highfine Biotech
Market Cap: CN¥5.6b
Manufactures and sells chemicals for pharmaceutical research and development, and API production companies in China.
301393
CN¥52.79
7D
-7.4%
1Y
16.0%
PharmaResources (Shanghai)
Market Cap: CN¥4.4b
Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.
301230
CN¥32.31
7D
-6.6%
1Y
27.5%
GlaxoSmithKline Pakistan
Market Cap: PK₨126.9b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨398.38
7D
-0.09%
1Y
39.2%
Ever Supreme Bio Technology
Market Cap: NT$14.0b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$159.50
7D
-1.2%
1Y
-2.8%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.86
7D
-3.4%
1Y
121.7%
Medtide
Market Cap: HK$4.3b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$30.60
7D
0%
1Y
n/a
Aarti Drugs
Market Cap: ₹44.8b
Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.
524348
₹491.15
7D
0.1%
1Y
0.2%
Rubicon Research
Market Cap: ₹103.3b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹627.20
7D
1.5%
1Y
n/a
DongKook Pharmaceutical
Market Cap: ₩778.9b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩17,410.00
7D
-1.5%
1Y
-1.9%
Puma Biotechnology
Market Cap: US$301.8m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.99
7D
17.5%
1Y
108.0%
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.42
7D
2.8%
1Y
70.0%
SMO ClinPlusLTD
Market Cap: CN¥3.7b
Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.
301257
CN¥47.33
7D
-9.8%
1Y
52.8%
SIGA Technologies
Market Cap: US$468.3m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.54
7D
-21.0%
1Y
-13.6%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥9.4b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥40.22
7D
-6.1%
1Y
3.3%
Procter & Gamble Health
Market Cap: ₹96.9b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹5,834.70
7D
-5.5%
1Y
4.8%
Zhejiang Hisun Pharmaceutical
Market Cap: CN¥12.7b
Engages in the research, development, production, and sale of biological and generic drugs in China.
600267
CN¥10.93
7D
-2.5%
1Y
26.1%